1. Logue CM, Moos RH. Positive perimenstrual changes: toward a new perspective on the menstrual cycle. J Psychosom Res 1988;32(1): 31-40
2. Lee KA, Rittenhouse CA Prevalence of perimenstrual symptoms in employed women. Women Health 1991; 17(3): 17-32
3. Faratian B, Gaspar A, O'Brien PM, Johnson IR, Filshie GM, Prescott P. Premenstrual syndrome: weight, abdominal swelling, and perceived body image. Am J Obstet Gynecol 1984;150(2):200-4
4. Ader DN, South-Paul J, Adera T, Deuster PA. Cyclical mastalgia: prevalence and associated health and behavioural factors. J Psychosom Obstet Gynaecol 2001; 22(2): 71-76
5. Reid RL, Yen SS. Premenstrual syndrome. Am J Obstet Gynecol 1981; 139(1): 85-104.
6. Wood NF, Most A, Dery GK. Prevalence of perimenstrual symptoms. Am J Public Health 1982; 72:1257- 1264
7. Johnston SR, McChesney C, Bean JA. Epidemiology of premenstrual symptoms in a non clinical sample. I. Prevalence, natural history, and help seeking behaviour. J Reprod Med 33:340-346, 1988
8. Rivera-Tovar AD, Frank E. Late luteal phase dysphoric disorder in young women. Am J Psychiatry 1990; 147:1634-1636
9. Reid RL. Premenstrual syndrome. Curr Prob Obstet Gynecol and Fertil 1985; 8:(2): 1-57
10. American Psychiatric association: Diagnostic and statistical manual of mental Disorders, 4th edition. Washington, DC, American Psychiatric Association 1994 pp 717-718
11. Reid RL. Premenstrual syndrome. NEJM 1991; 324(17):1208-1210
12. Sassenrath EN, Rowell TE, Hendrickx AG. Perimenstrual aggression in groups of female rhesus monkeys. J Reprod.Fertil 1973; 34:509-513
13. Gilbert C, Gillman J. The changing pattern of food intake and appetite during the menstrual cycle of the baboon with a consideration of some of the controlling hormonal factors. S Afr J Med 1956; 21: 75-89
14. Kantero RL, WidholmO. Correlations of menstrual traits between adolescent girls and their mothers. Acta Obstet Gynecol. Scand. 1977 Suppl 14:30-42
15. Reid RL. Premenstrual syndrome: a time for introspection. Am J Obstet Gynecol 1986; 155(5): 921-926
16. Kirkham C, Hahn PM, Van Vugt DA, Carmichael JA, Reid RL. A randomized, double-blind, placebo-controlled, cross-over trial to assess the side effects of medroxyprogesterone acetate in hormone replacement therapy. Obstetrics & Gynecology 1991; 78(1): 93-97.
17. Bjorn I, Bixo M, Nojd KS, Nyberg S, Backstrom T. Negative mood changes during hormone replacement therapy: a comparison between two progestogens. Am J Obstet Gynecol 2000;183(6): 1419-26
18. O'Brien PM. Backstrom T. Brown C. Dennerstein L. Endicott J. Epperson CN. Eriksson E. Freeman E. Halbreich U. Ismail KM. Panay N. Pearlstein T. Rapkin A. Reid R. Schmidt P. Steiner M. Studd J. Yonkers K. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Women's Mental Health 2011; 14(1):13-21
19. Steiner M. Premenstrual Dysphoric Disorder: An update. Gen Hosp Psychiatry 1996; 18: 244-250.
20. Reid RL. Endogenous opioid activity and the premenstrual syndrome. Lancet 1983; 2(8353):786.
21. Endicott J, Nee J, Harrison W (2006) Daily Record of Severity of Problems (DRSP): reliability and validity. Arch Women's Ment Health 9:41–49
22. Steiner M, MacDougall M, Brown E (2003) The premenstrual symptoms screening tool (PSST) for clinicians. Arch Women's Ment Health 6:203–209
23. Reid RL, Yen SS. The premenstrual syndrome.  Clinical Obstetrics & Gynecology 1983; 26(3): 710-718.
24. Rubinow DR, Schmidt PJ, Roca CA. Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry 1998; 44(9); 839-850
25. Halbreich U, Kahn LS. Role of estrogen in the aetiology and treatment of mood disorders. CNS Drugs 2001; 15(10): 797-817
26. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001; 58(6): 529-34
27. Hahn PM, Wong J, Reid RL. Menopausal-like hot flushes reported in women of reproductive age. Fertil Steril 1998; 70(5): 913-918.
28. Casper RF, Graves GR, Reid RL. Objective measurement of hot flushes associated with the premenstrual syndrome. Fertil Steril 1987; 47(2): 341-344.
29. Stearns V, Isaacs C, Rowland J, Crawford J, Ellis MJ, Kramer R, Lawrence W, Hanfelt JJ, Hayes DF. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann Oncol 2000;11(1):17-22
30. Lipsett DR. in Notman M, Nadelson C eds. The Painful Woman: Complaints, Symptoms and Illness. New York, Plenum Press 1982 3:147
31. MacGregor GA, Markander ND, Roulston JE, Jones JC, de Wardener HE. Is “idiopathic” edema idiopathic? Lancet 1979; 1:397-400
32. Minton JP, Foecking MK, Webster DJ, Matthews RH.  Caffeine, cyclic nucleotides, and breast disease. Surgery 1979; 86:105-109
33. Rossignol AM, Bonnlander H. Caffeine-containing beverages, total fluid consumption, and premenstrual syndrome. Am J Publ Health 1990; 80:1106-1110
34. Mello NK, Mendelson JH, Lex BW.  Alcohol use and premenstrual symptoms in social drinkers. Psychopharmacology 1990; 101(4): 448- 455
35. Diamond M, Simonson CD, DeFronzo RA. Menstrual cyclicity has a profound effect on glucose homeostasis. Fertil Steril 1989; 52: 204-208.
36. Young SN. Clinical nutrition: 3. The fuzzy boundary between nutrition and psychopharmacology. CMAJ 2002; 166 (2): 205-209
37. Sayegh,R. Schiff,I. Wurtman,J. Spiers,P. McDermott,J. Wurtman,R.  The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome. Obstet Gynecol 1995; 86(4):1-8
38. Thys-Jacobs S, Starkey P, Bernstein D, Tian J. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. Am J Obstet Gynecol 1998 ; 179(2):444-52
39. Prior JC, Vigna Y, Sciarretta D, Alojado N, Schulzer M. Conditioning exercise decreases premenstrual symptoms: a prospective, controlled 6-month trial. Fertil Steril 1987 Mar;47(3):402-8
40. Steege JF, Blumenthal JA. The effects of aerobic exercise of premenstrual symptoms in middle aged women: A preliminary study. J Psychosom Res 1993; 37 (2):127-133.
41. Mira M, McNeil D, Fraser IS, Vizzard J, Abraham S. Mefenamic acid in the treatment of premenstrual syndrome. Obstet Gynecol 1986;68:395-398
42. Wood C, Jakubowicz D. The treatment of premenstrual symptoms with mefenamic acid. Br J Obstet Gynaecol 1980; 87(7):627-30
43. Collins J, Crosignani PG, and the ESHRE Capri Working Group. Non Contraceptive Health Benefits of Combined Oral contraception. Human Reprod Update 2005; 11(5):513-525
44. Yonkers KA et al. Efficacy of a new low dose oral contraceptive with drospirenone in PMDD. Obstet Gynecol 2005; 106(3): 492-501
45. Wyatt KM, Dimmock PW,  Jones PW, O’Brien PMS. Efficacy of vitamin B6 in treatment of premenstrual syndrome: systematic review. BMJ 1999: 318: 1375-1381
46. Maddocks S, Hahn P, Moller F, Reid RL. A double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome. Am J Obstet Gynecol 1986; 154(3): 573-581.
47. Wyatt K, Dimmock P,  Jones P, Obhrai M, O’Brien PMS. Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review. BMJ 2001; 323 (7316); 776-780
48. Budeiri D, Li Wan Po A, Dornan JC. Is Evening Primrose Oil of value in the treatment of premenstrual syndrome? Controlled Clin Trials 1996; 17:60-68
49. Gorins A, Perret F, Tourant B, Rogier C, Lipszyc J. A French double-blind crossover study (danazol versus placebo) in the treatment of severe fibrocystic breast disease. Eur J Gynaecol Oncol 1984;5(2):85-9
50. Hahn PM, Van Vugt DA, Reid RL. A randomized placebo controlled crossover trial of danazol for the treatment of premenstrual syndrome. Psychoneuroendocrinology 1995; 20 (2):193-209.
51. Messinis IE, Lolis D. Treatment of premenstrual mastalgia with Tamoxifen. Acta Obstet Gynecol scand 1988; 67-307-309
52. O'Brien PM, Craven D, Selby C, Symonds EM Treatment of premenstrual syndrome by spironolactone. Br J Obstet Gynaecol 1979 ; 86(2): 142-7
53. Mauri M, Reid RL, MacLean AW. Sleep in the premenstrual phase: a self-report study of PMS patients and normal controls. Acta Psychiat Scand 1988; 78(1): 82-86.
54. Harrison WM, Endicott J, Nee J. Treatment of premenstrual dysphoria with alprazolam. A controlled study. Arch Gen Psychiatry 1990; 47(3): 270-5
55. Berger CP, Presser B. Alprazolam in the treatment of two subsamples of patients with late luteal phase dysphoric disorder: A double blind placebo controlled crossover study. Obstet Gynecol 1994; 84: 379-385
56. Landen M, Eriksson O, Sundblad C, Andersch B, Naessen T, Eriksson E. Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo. Psychopharmacology 2001; 155(3): 292-8
57. MacGregor A.  Migraine associated with menstruation. Funct Neurol 2000; 15 Suppl 3:143-153
58. De Lignieres B, Vincens M, Mauvais-JarvisP et al. Prevention of menstrual migraine by percutaneous oestradiol. Br Med J 1986; 293:1540
59. Magos AL, Zilkha KJ, Studd JW. Treatment of menstrual migraine by oestradiol implants. J Neurol Neurosurg Psychiattry 1983; 46: 1044-1046
60. Salonen R, Saiers J. Sumatriptan is effective in the treatment of menstrual migraine; a review of prospective studies and retrospective analyses. Cephalgia 1999; 19:16-19
61. Murray SC, Muse KN.Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and "add-back" therapy. Fertil Steril 1997; 67(2): 390-3
62. Case AM, Reid RL. Effects of the menstrual cycle on medical disorders. Arch  Intern Med 1998; 158(13):1405-1412.
63. Steiner M, Korzekwa M, Lamont J, Stewart D, Carter D, Misri S, Reid RL, Steinberg S, Berger C, Grover D. Fluoxetine in the treatment of premenstrual dysphoria. NEJM 1995; 332(23): 1529-1534.
64. Dimmock PW, Wyatt KM, Jones PW, O’Brien PM. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 2000: 356 (9236): 1131-1136
65. Steiner M, Korzekwa M, Lamont J, Wilkins A. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria. Psychopharmacology Bull 1997; 33(4): 771-774
66. Muse KN, Cetel NS, Futterman L, Yen SSC. The premenstrual syndrome: Effects of "medical ovariectomy". NEJM 1984; 311: 1345-1349.
67. Mezrow G, Shoupe D, Spicer D, Lobo R, Leung B, Pike M. Depot leuprolide acetate with estrogen and progestin add back for long-term treatment of premenstrual syndrome. Fertil Steril 1994; 62(5): 932-937
68. Casper RF, Hearn MT.  The effect of hysterectomy and bilateral oophorectomy in women with severe premenstrual syndrome. Am J Obstet Gynecol 1990; 162: 105-109.
69. Casson P, Hahn P, VanVugt DA, Reid RL.  Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am J Ob Gynecol 1990;162:99-102